ArticleSignal transduction and targeted therapy2023

Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1'-CN-4-aza-7,9-dideazaadenosine C-nucleoside.

Qifan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.